AtriCure, Inc. $201.2 Million Follow-on Offering

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a SEC-registered follow-on offering of 4,573,863 shares of common stock of AtriCure, Inc., including the full exercise by the underwriters of their option to purchase additional shares of common stock. The common stock is listed on the Nasdaq Global Market under the symbol “ATRC.”

Based in Mason, Ohio, AtriCure, Inc. is a provider of innovative technologies for the treatment of atrial fibrillation and related conditions.

The Davis Polk corporate team included partner Alan F. Denenberg and associates Beth LeBow and Sylvia Zaich. The tax team included counsel Ethan R. Goldman and associate Danielle Rapaccioli. The intellectual property and technology transactions team included partner Pritesh P. Shah and associate Yifu Chen. Members of the Davis Polk team are based in the Northern California and New York offices.